Showing results (1271-1280 of 1,566) with videos related to
Sort By:
Pageof 157
Asia-Pacific Journal of Clinical Oncology|August 24, 2016
Application of novel quantitative techniques for fluorodeoxyglucose positron emission tomography/computed tomography in patients with non-small-cell lung cancerDuo Wang, Eng-Siew Koh, Joseph Descallar, et al.Asia-Pacific Journal of Clinical Oncology|June 30, 2017
Clinical and palliative care outcomes for patients of poor performance status treated with antiprogrammed death-1 monoclonal antibodies for advanced melanomaAnnie Wong, Molly Williams, Donna Milne, et al.Asia-Pacific Journal of Clinical Oncology|July 10, 2018
Primary uterine lymphoma: The Yokohama Cooperative Study Group for Hematology (YACHT) studyYoshimi Ishii, Shin Fujisawa, Taiki Ando, et al.Asia-Pacific Journal of Clinical Oncology|July 10, 2018
Regression of a metastatic lung mass after receiving whole brain irradiation: Can the abscopal effect cross the blood-brain barrier?Cheng-Hao Chuang, Jui-Feng Hsu, Yu-Ting Shen, et al.Asia-Pacific Journal of Clinical Oncology|April 19, 2019
Risk factors for neutropenia and febrile neutropenia following prophylactic pegfilgrastimMirinae Lee, Jeong Yee, Jae Youn Kim, et al.Asia-Pacific Journal of Clinical Oncology|August 12, 2020
v-myb avian myeloblastosis viral oncogene homolog expression is a potential molecular diagnostic marker for B-cell acute lymphoblastic leukemiaMarcela Concepción Caballero-Palacios, Vanessa Villegas-Ruiz, Josselen Carina Ramírez-Chiquito, et al.Asia-Pacific Journal of Clinical Oncology|August 12, 2020
MR-guided simulation is superior than FDG/PET-guided simulation for local control in nasopharyngeal cancer patients treated with intensity-modulated radiotherapyMete Gundog, Hatice Basaran, Serap Dogan, et al.Asia-Pacific Journal of Clinical Oncology|August 14, 2020
The adverse events associated with combination immunotherapy in cancers: Challenges and chancesMinglei Zhuo, Yujia Chi, Ziping WangAsia-Pacific Journal of Clinical Oncology|August 7, 2020
The changing paradigm of managing Merkel cell carcinoma in Australia: An expert commentaryDavid L Kok, Annie Wang, Wen Xu, et al.Asia-Pacific Journal of Clinical Oncology|August 7, 2020
Programmed cell death 1 (PD-1)/PD-ligand 1(PD-L1) inhibitors-related pneumonitis in patients with advanced non-small cell lung cancerYuxin Sun, Chi Shao, Shan Li, et al.Pageof 157